NCT05223842

Brief Summary

Anhedonia is characterized by loss of interest or pleasure. The proposed pilot study would be the first to test an innovative, neuroscience-informed intervention in mothers reporting depressive symptoms and stress to enhance positive emotionality with the goal of preventing anhedonia and associated emotional disturbances in their children. This study will recruit dyads (mothers and their children) for the intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
74

participants targeted

Target at P25-P50 for not_applicable depression

Timeline
Completed

Started Dec 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 4, 2021

Completed
2 months until next milestone

Study Start

First participant enrolled

December 1, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

February 4, 2022

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 20, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 20, 2023

Completed
Last Updated

February 1, 2023

Status Verified

January 1, 2023

Enrollment Period

1.1 years

First QC Date

October 4, 2021

Last Update Submit

January 31, 2023

Conditions

Keywords

DepressionAnhedoniaStressRewardMental disordersMood disorders

Outcome Measures

Primary Outcomes (3)

  • Child perceived stress

    The National Institutes of Health Toolbox Perceived Stress survey consists of 10 questions with options ranging in value from 1 to 5 to assess self-reported perceived stress for children (self- and parent-report). The minimum score is 10 and the maximum score is 50, with higher values meaning greater stress. Hypothesis 1a: Children in the F-PPE group will show lower post-intervention perceived stress compared to the written information group.

    8 weeks

  • Child emotional distress

    The Patient-Reported Outcomes Measurement Information System (Anxiety, Depression, Anger) short form consists of questions with five response options ranging in value from 1 to 5 to assess self-reported anxiety, depression, anger and irritability for participants (parent, child, and parent report). Total scores on the emotional distress scales for children range from 33 to 165 for self-report and 26 to 130 for parent report, with higher scores reflect greater distress. Hypothesis 1b: Children in the F-PPE group will show lower post-intervention emotional distress compared to the written information group.

    8 weeks

  • Child positive affect

    Positive affect will be assessed using the positive affect scale of the Positive and Negative Affect Schedule for Children administered through ecological momentary assessment over 10 days. Children rate their current affect on 5 items with a 1 to 5 scale for total scores from 5 to 25, with greater values reflecting greater positive affect. Hypothesis 2a: Children in the F-PPE group will show relative increases in daily positive affect from pre- to post-intervention compared to the written information condition. Hypothesis 2b: Changes in positive affect will partly account for F- PPE effects on child perceived stress and emotional distress. Hypothesis 2c: Changes in positive affect will partly account for F- PPE effects on child perceived stress and emotional distress.

    8 weeks

Secondary Outcomes (1)

  • Child reward learning

    8 weeks

Study Arms (2)

Family Promoting Positive Emotions Group

EXPERIMENTAL

Each dyad (mother and their child) will receive 8 sessions of promoting positive emotions intervention with a clinician for 8 weeks.

Behavioral: Family Promoting Positive Emotions (F-PPE)

Written Information Group

ACTIVE COMPARATOR

Mothers will be sent written information and resources on depression for 8 weeks over email.

Behavioral: Written Information

Interventions

F-PPE is an 8-session dyadic intervention designed to enhance positive emotionality and buffer against the effects of stress on anhedonia in children. The intervention will be administered online through videoconferencing sessions with a clinician to mothers and their children.

Family Promoting Positive Emotions Group

Mothers assigned to the Written Information condition will receive email newsletters providing resources relevant to depression.

Written Information Group

Eligibility Criteria

Age8 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 and older who report at least subthreshold current depressive symptoms (\> score of 8 on the Patient Health Questionnaire) and moderate COVID-19-related stress
  • Can read and speak in English.
  • Have access to a computer with a videoconferencing platform.
  • Age 8-12 years who can participate with their biological mother who is 18 years or older that meets the above criteria.
  • Can read and speak in English.

You may not qualify if:

  • Current substance use disorder.
  • Intellectual disabilities.
  • Diagnosis of mania or bipolar disorder.
  • Diagnosis of a psychotic disorder (e.g., schizophrenia).
  • Visual or hearing impairments that interfere with completing study measures and sessions.
  • Diagnoses of autism spectrum disorders or developmental disorders.
  • Intellectual disabilities.
  • Diagnosis of mania or bipolar disorder.
  • Diagnosis of a psychotic disorder (e.g., schizophrenia).
  • Currently experiencing depressive symptoms.
  • Visual or hearing impairments that interfere with completing study measures and sessions.
  • Offspring of mothers who have previously participated in the study with another biological child.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vanderbilt University

Nashville, Tennessee, 37203, United States

Location

Related Publications (1)

  • Burkhouse KL, Dao A, Argiros A, Granros M, Cardenas E, Dickey L, Feurer C, Hill K, Pegg S, Venanzi L, Kujawa A. Targeting positive valence systems function in children of mothers with depressive symptoms: A pilot randomized trial of an RDoC-Informed preventive intervention. Behav Res Ther. 2023 Sep;168:104384. doi: 10.1016/j.brat.2023.104384. Epub 2023 Aug 9.

Related Links

MeSH Terms

Conditions

DepressionAnhedoniaDepressive DisorderBehavioral SymptomsMood DisordersMental Disorders

Condition Hierarchy (Ancestors)

BehaviorNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Autumn J Kujawa, PhD

    Vanderbilt University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Psychology and Human Development

Study Record Dates

First Submitted

October 4, 2021

First Posted

February 4, 2022

Study Start

December 1, 2021

Primary Completion

January 20, 2023

Study Completion

January 20, 2023

Last Updated

February 1, 2023

Record last verified: 2023-01

Data Sharing

IPD Sharing
Will share

Deidentified data will be available for sharing by request.

Time Frame
Immediately after publication.
Access Criteria
Principal investigator will review requests and grant access depending on the research question/plan and overlap with ongoing analyses in the laboratory.

Locations